Billiau A D, Sefrioui H, Overbergh L, Rutgeerts O, Goebels J, Mathieu C, Waer M
Laboratory of Experimental Transplantation, Catholic University of Leuven, Belgium.
Transplantation. 2001 Jan 27;71(2):292-9. doi: 10.1097/00007890-200101270-00022.
We have previously shown that allogeneic bone marrow (BM) chimeras preconditioned with total lymphoid irradiation and low-dose total body irradiation (TLI/TBI) develop a stronger graft-versus-leukemia (GVL) effect than chimeras preconditioned with high-dose total body irradiation only (TBI). Here, we report on the possible role of cytokines in the mechanism underlying this GVL effect.
Splenic mRNA levels of the cytokines interleukin (IL)-1, IL-2, IL-4, IL-6, IL-7, IL-10, IL-12, IL-15, interferon-gamma, tumor necrosis factor-alpha, and transforming growth factor-beta (TGF-beta), and of inducible nitric oxide synthetase were determined by reverse transcription-polymerase chain reaction in TLI/TBI- or TBI-conditioned C3H/AKR BM chimeras challenged with AKR-type BW5147.3 leukemia cells. Ex vivo TGF-beta protein production by splenocytes was determined using ELISA. The possibility that cytokines influence the GVL effect by modulating the activity of IL-2-activated lymphocytes (LAK cells) was investigated by in vitro assays on donor-type BM cells.
Of all cytokine mRNA levels studied, those of TGF-beta and IL-7 were different between groups; both were significantly more elevated in TBI- than in TLI/ TBI-conditioned or normal mice. Differences were apparent after conditioning and were not influenced by additionally injected BM or leukemia cells. Cultured splenocytes of TBI-conditioned animals produced significantly more TGF-beta protein than those of TLI/TBI-conditioned ones or normal controls. r-TGF-beta but not r-IL-7 suppressed in vitro LAK activity of donor-type BM cells against BW5147.3 cells in a dose-dependent way.
High-dose TBI-induced, host-derived splenic TGF-beta may inhibit generation of LAK cells from subsequently transplanted donor BM cells, suppressing their capacity to generate cytotoxicity upon injection of leukemia cells. The cytokine profile, induced by irradiation in host hematopoietic organs, can significantly modify posttransplant immunological processes such as the GVL effect and graft-versus-host disease (GVHD).
我们之前已经表明,经全淋巴照射和低剂量全身照射(TLI/TBI)预处理的异基因骨髓(BM)嵌合体比仅经高剂量全身照射(TBI)预处理的嵌合体产生更强的移植物抗白血病(GVL)效应。在此,我们报告细胞因子在这种GVL效应潜在机制中的可能作用。
通过逆转录聚合酶链反应测定在TLI/TBI或TBI预处理的C3H/AKR BM嵌合体中,用AKR型BW5147.3白血病细胞攻击后,细胞因子白细胞介素(IL)-1、IL-2、IL-4、IL-6、IL-7、IL-10、IL-12、IL-15、干扰素-γ、肿瘤坏死因子-α和转化生长因子-β(TGF-β)以及诱导型一氧化氮合酶的脾脏mRNA水平。使用酶联免疫吸附测定法测定脾细胞的体外TGF-β蛋白产生量。通过对供体型BM细胞的体外试验研究细胞因子是否通过调节IL-2激活的淋巴细胞(LAK细胞)的活性来影响GVL效应。
在所研究的所有细胞因子mRNA水平中,TGF-β和IL-7的水平在各组之间存在差异;两者在TBI预处理的小鼠中均显著高于TLI/TBI预处理的小鼠或正常小鼠。差异在预处理后即很明显,且不受额外注射的BM或白血病细胞的影响。TBI预处理动物的培养脾细胞产生的TGF-β蛋白明显多于TLI/TBI预处理的动物或正常对照。重组TGF-β而非重组IL-7以剂量依赖的方式抑制供体型BM细胞对BW5147.3细胞的体外LAK活性。
高剂量TBI诱导的宿主来源的脾脏TGF-β可能抑制随后移植的供体BM细胞产生LAK细胞,抑制它们在注射白血病细胞后产生细胞毒性的能力。宿主造血器官照射诱导的细胞因子谱可显著改变移植后的免疫过程,如GVL效应和移植物抗宿主病(GVHD)。